Why Procter & Gamble’s Quieter Dividend Outpaces Johnson & Johnson’s Growth Story
Both Johnson and Johnson and Procter & Gamble just refreshed decades-long dividend streaks, but one company has a corporate event on the horizon that has derailed other legendary payout records before.
Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) and Procter & Gamble (NYSE:PG) both recently refreshed their long dividend records. J&J posted Q1 2026 revenue of $24.06 billion and P&G closed fiscal 2026 with core EPS of $6.89. One is heading into a spinoff while the other stays intact, and that structural difference defines the comparison.
How Each Payout Actually Landed This Cycle
J&J lifted its quarterly dividend to $1.34 per share, with an ex-date of August 25, 2026, and a September 8 payment. The trailing 12-month total is $5.28, with the forward annualized total at $5.36. Growth is doing the heavy lifting: Darzalex at $4.21 billion (+22.5%) and Tremfya at $2.05 billion (+68.3%) more than offset Stelara’s revenue erosion of 55.7%.
P&G paid $1.0885 per share on August 17, 2026, with forward annualized of $4.354. Fiscal 2026 organic sales grew more than 1%, and management returned over $15 billion to shareowners, including more than $10 billion in dividends. Growth, not coverage, is the concern.
| Metric | JNJ | PG |
| Latest quarterly dividend | $1.34 | $1.0885 |
| Forward annualized | $5.36 | $4.354 |
| 1-year price change | +53.4% | −4.9% |
Where the Two Streaks Really Diverge
J&J is heading into a corporate event that has broken other long streaks. CFO Joe Wolk said the company is “on track for a mid-2027 separation” of DePuy Synthes, with more updates expected later in 2026. The precedent cuts both ways. The Kenvue separation in 2023 came and went without a rebase, and quarterly dividends rose from $1.13 in 2022 to $1.34 today. 3M’s payout did not survive its Solventum spinoff intact.
P&G has no such event. New CEO Shailesh Jejurikar said, “we continue to believe the strategy is right,” backing it with $2.8 billion of pre-tax productivity savings. Fiscal 2027 guidance still calls for $10 billion in dividends and roughly $5 billion in buybacks, absorbing a $1 billion after-tax commodity headwind.
A Price Paradox Investors Keep Missing
The stock with the quieter payout has been the worse performer. PG is up just 1.3% year to date, while JNJ has climbed 28.5% YTD. Pipeline strength, not payout policy, drove that gap. CEO Duato reminded investors that the company has 28 platforms each generating more than $1 billion in annual revenue.
Verdict
For a retirement income investor wondering which payout is less likely to be disturbed by a corporate action, the answer is P&G. No separation is planned, coverage is generous, and productivity is funding the raise. (If you want a broader shortlist of 50-year raisers screened by valuation, we put 10 of them in a free Dividend Kings report.)
J&J’s payout looks equally covered, with FY2025 operating cash flow of $24,530 million against dividends paid of $12,381 million, but the DePuy Synthes carve-out is exactly the type of event that has tested streaks before. One specific thing to watch is J&J’s Enterprise Business Review on December 8. If management reaffirms the dividend framework alongside the separation terms, the dividend streak will likely continue uninterrupted.
Contact [email protected] for any questions or corrections.







